7.37
3.15%
-0.24
Handel nachbörslich:
7.35
-0.02
-0.27%
Finanzdaten der Treace Medical Concepts Inc-Aktie (TMCI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
17.85%
51.11
|
62.21 | 40.76 | 41.95 | 42.20 |
Cost Of Revenue |
11.70%
10.13
|
11.47 | 7.998 | 7.675 | 8.039 |
Gross Profit |
19.24%
40.98
|
50.74 | 32.76 | 34.28 | 34.16 |
Operating Expenses
|
4.21%
59.95
|
57.52 | 50.58 | 47.33 | 47.93 |
Interest Income/Expense |
1.00%
1.317
|
1.304 | 1.296 | 1.282 | 1.285 |
Benefits Costs and Expenses |
1.88%
69.78
|
68.49 | - | - | 55.65 |
Costs And Expenses |
1.88%
69.78
|
68.49 | 58.58 | 55.01 | 55.65 |
Operating Income/Loss |
179.68%
-18.97
|
-6.782 | -17.82 | -13.05 | -13.78 |
Income/Loss From Continuing Operations Before Tax |
197.34%
-18.68
|
-6.281 | 40.76 | -12.27 | -13.45 |
Income/Loss From Continuing Operations After Tax |
197.34%
-18.68
|
-6.281 | -17.52 | -12.27 | -13.45 |
Net Income/Loss
|
197.34%
-18.68
|
-6.281 | -17.52 | -12.27 | -13.45 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
21,544%
61.79
|
0.2855 | 61.56 | 61.38 | 58.72 |
Diluted Average Shares |
21,544%
61.79
|
0.2855 | 61.56 | 61.38 | 58.72 |
Basic Earnings Per Share |
200.00%
-0.30
|
-0.10 | -0.28 | -0.20 | -0.23 |
Diluted Earnings Per Share |
200.00%
-0.30
|
-0.10 | -0.28 | -0.20 | -0.23 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):